Comparison of Home Versus Clinic Kegel Rehabilitation in Women With Urinary Incontinence in the Tabuk Region

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-50
SponsorUniversity of Tabuk

About this trial

Urinary incontinence is a common condition among women that significantly affects physical health, emotional well-being, social participation, and overall quality of life. Pelvic floor muscle training recommended as the first-line conservative treatment for urinary incontinence. While clinic-based rehabilitation provides direct supervision by healthcare professionals, home-based Kegel exercise programs offer greater convenience and accessibility. However, limited evidence exists regarding the comparative effectiveness of these approaches among women in Saudi Arabia.

The study aims to compare the effectiveness of home-based Kegel exercises and clinic-based rehabilitation programs in improving pelvic floor muscle strength, reducing urinary incontinence symptoms, and enhancing quality of life among women with urinary incontinence in the Tabuk region.

This study will employ a randomized controlled trial (RCT) design. Eligible women diagnosed with urinary incontinence will be recruited from the Maternity and Children Hospital, Tabuk. Participants will be randomly assigned to one of two groups:

* Group A: Home-based Kegel exercise program. * Group B: Supervised clinic-based pelvic floor rehabilitation program. Both interventions will be conducted over a 12-week period. Outcome Measures

The effectiveness of the interventions will be evaluated using:

* Perineometer measurements to assess pelvic floor muscle strength. * Pad Test to assess urinary leakage severity. * King's Health Questionnaire (KHQ) to evaluate quality of life. * Adherence records to monitor compliance with the exercise program. The assessments will be conducted at baseline, week 8, and week 12.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Female participants aged 20-50 years.

Diagnosed with urinary incontinence.

Able to understand study instructions.

Willing to provide informed consent

Disqualifiers

Delivery within the previous 3 months.

Gynecological surgery during the previous 3 months.

Lower urinary tract surgery during the previous 3 months.

Postmenopausal women.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Home -Based Kegel Trainer Exercises (Kegel Trainer Application) will be used by the participants at home for training the pelvic floor muscles over 9 levels.

    Other intervention

    Kegel exercises are designed to focus on strengthening the weak pelvic floor muscles by using Kegel Trainer Application over 9 levels.

  • Clinic-Based Rehabilitation Program will consist of physiotherapist supervised pelvic floor strengthening exercises for the participant , 2 times per week for 3 months

    Other intervention

    Clinic-Based Rehabilitation Program will consist of physiotherapist supervised pelvic floor strengthening exercises for the participant , 2 times per week for 3 months

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: Home-Based Kegel ExercisesExperimental treatment 1 intervention
Group B: Clinic-Based Rehabilitation ProgramExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Perineometer

Pelvic floor muscle strength will be measured using a perineometer min 0 cmH₂O and max 300 cmH₂O. Higher scores indicate greater pelvic floor muscle strength

Time frame
From enrollment to the end of treatment at 12 weeks

Secondary outcomes

1

long-term Pad Test

Urinary leakage severity will be measured using the long-term Pad Test. Minimum value of 0 g. Higher values indicate greater urinary leakage and therefore worse urinary incontinence. Lower values indicate less urinary leakage and better outcome.

Time frame
From enrollment to the end of treatment at 12 weeks
2

King's Health Questionnaire

• Quality of life will be measured using the King's Health Questionnaire with min score 0 and max score 100 for each domain. Lower scores indicate better quality of life.

Time frame
From enrollment to the end of treatment at 12 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: